A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the plasma concentration and pharmacodynamics
effects of warfarin 5 mg, in the presence or absence of belinostat 1,000 mg/m².
Pharmacokinetic evaluation of belinostat 1,000 mg/m² and metabolites in the presence of
warfarin 5 mg.